Streptococcal glycoprotein-induced tumour cell growth inhibition involves the modulation of a pertussis toxin-sensitive G protein
1996

Streptococcal Glycoprotein and Tumor Cell Growth Inhibition

publication Evidence: moderate

Author Information

Author(s): J Yoshida, S Takamura, S Suzuki, M Nishio

Primary Institution: Kanazawa Medical University

Hypothesis

Does the streptococcal glycoprotein (SAGP) inhibit tumor cell growth through modulation of G proteins?

Conclusion

The study found that SAGP inhibits tumor cell growth by modulating Gi protein activity.

Supporting Evidence

  • SAGP inhibited the incorporation of nucleic acid precursors into Meth A cells.
  • The growth-inhibitory effect of SAGP was diminished by pertussis toxin.
  • SAGP caused an increase in labelling of the Gi protein in Meth A cells.

Takeaway

A special protein from bacteria can stop cancer cells from growing by changing how certain proteins in the cells work.

Methodology

The study involved in vitro experiments with murine fibrosarcoma cells to assess the effects of SAGP on cell growth and nucleic acid synthesis.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication